June 17, 2013
/PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day on
Wednesday, June 26, 2013
8:30 a.m. to 12:30 p.m. (EDT)
All interested parties are invited to listen as Chairman and Chief Executive Officer
Josef von Rickenbach
, Chief Financial Officer
and five additional members of the executive team provide a strategic overview of the Company's businesses through a series of presentations, followed by a question-and-answer session.
The live webcast will be accessible in the Investor Relations section of the Company's website at
. For those unable to listen to the live presentations, the event will be archived and available on the Company's website.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near
, PAREXEL operates in 78 locations in 52 countries around the world and has 14,400 employees. For more information about PAREXEL International visit
PAREXEL, Perceptive Informatics, LIQUENT, and HERON are registered trademarks of PAREXEL International Corporation or its affiliates.
CONTACT: Jill Baker, Corporate Vice President of Investor Relations
SOURCE PAREXEL International Corporation